XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.21.1

GOODWILL AND PURCHASED INTANGIBLE ASSETS | 9 Months Ended
--- | ---
Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND PURCHASED INTANGIBLE ASSETS | GOODWILL AND PURCHASED INTANGIBLE ASSETS Goodwill Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in the prior business combinations. We have four reportable segments and six reporting units. For additional details, refer to Note 18 “Segment Reporting and Geographic Information” of the Notes to the Condensed Consolidated Financial Statements. The following table presents changes in goodwill carrying value during the nine months ended March 31, 2021(1):
(In thousands) | Wafer Inspection and Patterning |  | Global Service and Support (“GSS”) |  | Specialty Semiconductor Process |  | PCB and Display |  | Component Inspection |  | Total
Balance as of June 30, 2020 | $ | 416,840 |  |  | $ | 25,908 |  |  | $ | 681,858 |  |  | $ | 907,221 |  |  | $ | 13,575 |  |  | $ | 2,045,402 |
Goodwill disposal from sale of business (2) | — |  |  | — |  |  | — |  |  | (34,250) |  |  | — |  |  | (34,250) |
Foreign currency adjustments | 35 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 35 |
Balance as of March 31, 2021 | $ | 416,875 |  |  | $ | 25,908 |  |  | $ | 681,858 |  |  | $ | 872,971 |  |  | $ | 13,575 |  |  | $ | 2,011,187 |
_________________ (1)No goodwill was assigned to the Other reporting unit and, accordingly, it was excluded from the table above. (2)Refer to the Non-controlling Interest section of Note 10 “Equity, Long-term Incentive Compensation Plans and Non-Controlling Interest” for more information on the sale of PixCell Medical Technologies, Ltd. ("PixCell"). Goodwill is not subject to amortization but is tested for impairment annually during the third fiscal quarter, as well as whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In testing goodwill for impairment, we utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. When performing the qualitative assessment, we consider the following factors: stock price or market capitalization, changes in the industry and competitive environment, budget-to-actual revenue and profitability performance from prior year and projected revenue and profitability trends for future years at our reporting units. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a quantitative assessment by comparing the carrying value of net assets to the fair value of the reporting units. If the fair value is determined to be less than the carrying value, the amount of impairment is computed as the excess of the carrying value over the estimated fair value, not to exceed the carrying value of goodwill. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge. We performed the required annual goodwill impairment testing for all reporting units as of February 28, 2021, and concluded that goodwill was not impaired. As a result of our qualitative assessment, we determined that it was not necessary to perform the quantitative assessment at this time. The next annual assessment of goodwill by reporting unit is scheduled to be performed in the third quarter of the fiscal year ending June 30, 2022. For the fiscal year ended June 30, 2020, as a result of our annual goodwill impairment testing for all reporting units, we recorded $144.2 million and $112.5 million in impairment charges in the Specialty Semiconductor Process and PCB and Display reporting units, respectively, in the three months ended March 31, 2020. For additional details, refer to Note 7 “Goodwill and Purchased Intangible Assets” of the Notes to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. Purchased Intangible Assets The components of purchased intangible assets as of the dates indicated below were as follows:
|  |  |  |  | As of |  |  |  |  |  | As of |  |
(In thousands) |  |  | March 31, 2021 |  | June 30, 2020
Category | Range of Useful Lives (in years) |  | Gross Carrying Amount |  | Accumulated Amortization and Impairment |  | Net Amount |  | Gross Carrying Amount |  | Accumulated Amortization and Impairment |  | Net Amount
Existing technology | 4-8 |  | $ | 1,379,783 |  |  | $ | 458,711 |  |  | $ | 921,072 |  |  | $ | 1,269,883 |  |  | $ | 342,623 |  |  | $ | 927,260 |
Customer relationships | 4-9 |  | 305,817 |  |  | 123,228 |  |  | 182,589 |  |  | 305,817 |  |  | 98,754 |  |  | 207,063 |
Trade name / Trademark | 4-7 |  | 117,383 |  |  | 49,924 |  |  | 67,459 |  |  | 117,383 |  |  | 39,216 |  |  | 78,167 |
Backlog and other | <1-9 |  | 50,404 |  |  | 49,919 |  |  | 485 |  |  | 50,404 |  |  | 47,215 |  |  | 3,189 |
Intangible assets subject to amortization |  |  | 1,853,387 |  |  | 681,782 |  |  | 1,171,605 |  |  | 1,743,487 |  |  | 527,808 |  |  | 1,215,679 |
In-process research and development |  |  | 66,084 |  |  | 100 |  |  | 65,984 |  |  | 175,834 |  |  | 100 |  |  | 175,734 |
Total |  |  | $ | 1,919,471 |  |  | $ | 681,882 |  |  | $ | 1,237,589 |  |  | $ | 1,919,321 |  |  | $ | 527,908 |  |  | $ | 1,391,413 |
Purchased intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be fully recoverable. The impairment indicator primarily includes the declines in our operating cash flows from the use of these assets. If the impairment indicators are present, we are required to perform a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to these long-lived assets to their carrying value. As of March 31, 2021, there were no impairment indicators for purchased intangible assets. Amortization expense for purchased intangible assets for the periods indicated below was as follows:
| Three Months Ended |  | Nine Months Ended
| March 31, |  | March 31,
(In thousands) | 2021 |  | 2020 |  | 2021 |  | 2020
Amortization expense - Cost of revenues | $ | 40,309 |  |  | $ | 36,850 |  |  | $ | 116,087 |  |  | $ | 108,835 |
Amortization expense - Selling, general and administrative | 12,063 |  |  | 17,724 |  |  | 37,793 |  |  | 60,237 |
Amortization expense - Research and development | 32 |  |  | 31 |  |  | 94 |  |  | 193 |
Total | $ | 52,404 |  |  | $ | 54,605 |  |  | $ | 153,974 |  |  | $ | 169,265 |
Based on the purchased intangible assets gross carrying amount recorded as of March 31, 2021, the remaining estimated annual amortization expense is expected to be as follows:
Fiscal year ending June 30: | Amortization (In thousands)
2021 (remaining three months) | $ | 52,249 |
2022 | 208,995 |
2023 | 207,904 |
2024 | 205,386 |
2025 | 193,168 |
2026 and thereafter | 303,903 |
Total | $ | 1,171,605 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration